By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
LONG-TERM ARCHIVING OF BENTHAM SCIENCE CONTENT
To ensure permanent access to our publications, Bentham Science has an agreement with Portico to have a long-term preservation of the content published in its journals.
Alberto Izzotti University of Genoa Genoa (Italy) Biography
Biography of Alberto Izzotti
Dr. Alberto Izzotti is MD, Specialist in Hygiene and Preventive Medicine, PhD in Toxicology, Full-Professor at the School of Medicine of the University of Genoa, Italy, Director of UOC Mutagenesis and Cancer Prevention at the National Research Institute for Cancer Research San Martino Hospital, Genoa, Italy. He has 30 years of experience in research devoted to the study of chronic-degenerative diseases, molecular medicine, cancer prevention, human biomonitoring, microarray analysis of gene, microRNA, and protein expression. Author of more than 200 papers. He was Principal Investigator of Research Projects supported by many international institutions including the US National Cancer Institute.